2016

Intern Spotlight: A Year in Review

Intern Spotlight: Huibert-Jan Joosse

Intern Spotlight: Gaby Ooms

Intern Spotlight: Linnea Celik

Intern Spotlight: Brian Tielrooij

Intern Spotlight: Anneke Johnson

November is ‘Intern Spotlight Month’ at Health Action International

Next Gen Advocates Excel at HAI/HP4L Summer School on Access to Medicines

Top Experts to Discuss Global Initiatives to Reduce Snakebite Death & Disability at WHA69 Side Event

Farewell to Access to Medicines Pioneer, Andrew Herxheimer

Insulin Still Unattainable for Many Living with Diabetes Worldwide: ACCISS Study Review in The Lancet D&E

2015

HAI/WHO Pharmaceutical Promotion Manual Still Key to Combating Promotion around the World

It’s Time Everyone Knows about Price Inequities in Insulin

HAI Holds Workshops on EU Medicines Policy & Access to Medicines in Eastern Europe

HAI urges MEPs to support key amendments to TTIP resolution

The EU-US Trade Deal Could Leave Europeans Sick

World Health Assembly Executive Board 136: YP-CDN, NWIA and HAI intervention on the WHO’s internship programme

HAI Launches Innovative Global Study to Improve Access to Insulin

In memory of our Foundation Board Chair, Atze Sybrandy

2014

Student Stop AIDS National Gathering an inspiring start to Access to Medicines Week

Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry

Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA

School's IN for summer: HAI staff and interns inspired by Utrecht University's course on pharmaceutical policy analysis

BMJ statins debate about scientific independence, not rigour

Progress on access to medicines at WHA67, but WHO funding sorely needed

World Health Assembly 67: HAI and KEI intervention on the Consultative Expert Working Group on Research and Development

World Health Assembly 67: HAI intervention on access to essential medicines

World Health Assembly 67: HAI intervention on the WHO's framework of engagement with non-state actors

Tamiflu review shows desperate need for full clinical trials data transparency

Governments must ensure Big Pharma’s expansion in Africa doesn’t impede generics supply